AlphaMaven AlphaMaven

Luma, a Life-Sciences Investor, Debuts a $410 Million Fund

Reported by Wsj
Sep 9, 2026· 1 min read
Save Post LinkedIn Email
Venture-capital funds are usually 10-year limited partnerships; Luma has stretched that to 15 years instead.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Wsj Luma, a Life-Sciences Investor, Debuts a $410 Million Fund